Riyadh – Mubasher: Dallah Healthcare Company achieved a net profit worth SAR 538.27 million in 2025, signaling a 14.23% growth from SAR 471.20 million in 2024.
The earnings per share (EPS) rose to SAR 5.32 in 2025 from SAR 4.83 in the previous year, according to a bourse filing.
The medical company generated 26.86% revenue growth to SAR 4.06 billion in 2025 compared to SAR 3.20 billion in 2024.
Cash Dividends
Dallah Healthcare announced the board’s decision to distribute interim cash dividends totaling SAR 50.55 million to the shareholders for the fourth quarter (Q4) of 2025.
The company will pay out SAR 0.50 per share, representing 5% of the share par value, for 101.10 million eligible shares.
Dallah Healthcare noted that “the total number of treasury shares not eligible for dividends is 471,821 shares as of this date.”
The company stated that the eligibility and distribution dates are 24 March and 7 April 2026, respectively.
It is worth noting that in the first nine months (9M) of 2025, Dallah Healthcare registered net profits worth SAR 421.72 million and revenue of SAR 2.95 billion.
